| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A learning experience from price negotiations for vaccines
|
Teerawattananon, Yot
|
|
2015
|
33 |
S1 |
p. A11-A12
nvt p.
|
artikel
|
| 2 |
Cost analysis of routine immunisation in Zambia
|
Schütte, Carl
|
|
2015
|
33 |
S1 |
p. A47-A52
nvt p.
|
artikel
|
| 3 |
Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru
|
Mezones-Holguin, Edward
|
|
2015
|
33 |
S1 |
p. A154-A166
nvt p.
|
artikel
|
| 4 |
Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil
|
Novaes, Hillegonda Maria Dutilh
|
|
2015
|
33 |
S1 |
p. A135-A142
nvt p.
|
artikel
|
| 5 |
Cost-effectiveness analysis of pneumococcal conjugate vaccine introduction in Paraguay
|
Kieninger, Martha Peña
|
|
2015
|
33 |
S1 |
p. A143-A153
nvt p.
|
artikel
|
| 6 |
Cost-effectiveness analysis of rotavirus vaccination in Argentina
|
Urueña, Analía
|
|
2015
|
33 |
S1 |
p. A126-A134
nvt p.
|
artikel
|
| 7 |
Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran
|
Javanbakht, Mehdi
|
|
2015
|
33 |
S1 |
p. A192-A200
nvt p.
|
artikel
|
| 8 |
Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras
|
Aguilar, Ida Berenice Molina
|
|
2015
|
33 |
S1 |
p. A167-A173
nvt p.
|
artikel
|
| 9 |
Cost-effectiveness analysis of the introduction of the pneumococcal conjugate vaccine (PCV-13) in the Egyptian national immunization program, 2013
|
Sibak, Mohammed
|
|
2015
|
33 |
S1 |
p. A182-A191
nvt p.
|
artikel
|
| 10 |
Cost-effectiveness of HPV vaccination in Belize
|
Walwyn, Leslie
|
|
2015
|
33 |
S1 |
p. A174-A181
nvt p.
|
artikel
|
| 11 |
Cost-effectiveness of pneumococcal conjugate vaccination in Croatia
|
Vučina, V. Višekruna
|
|
2015
|
33 |
S1 |
p. A209-A218
nvt p.
|
artikel
|
| 12 |
Cost-effectiveness of pneumococcal conjugate vaccination in Georgia
|
Komakhidze, T.
|
|
2015
|
33 |
S1 |
p. A219-A226
nvt p.
|
artikel
|
| 13 |
Cost-effectiveness of rotavirus vaccination in Albania
|
Ahmeti, Albana
|
|
2015
|
33 |
S1 |
p. A201-A208
nvt p.
|
artikel
|
| 14 |
Cost-effectiveness of rotavirus vaccination in Kenya and Uganda
|
Sigei, Charles
|
|
2015
|
33 |
S1 |
p. A109-A118
nvt p.
|
artikel
|
| 15 |
Costs and financing of routine immunization: Approach and selected findings of a multi-country study (EPIC)
|
Brenzel, Logan
|
|
2015
|
33 |
S1 |
p. A13-A20
nvt p.
|
artikel
|
| 16 |
Costs of routine immunization and the introduction of new and underutilized vaccines in Ghana
|
Le Gargasson, Jean-Bernard
|
|
2015
|
33 |
S1 |
p. A40-A46
nvt p.
|
artikel
|
| 17 |
Costs of routine immunization services in Moldova: Findings of a facility-based costing study
|
Goguadze, K.
|
|
2015
|
33 |
S1 |
p. A60-A65
nvt p.
|
artikel
|
| 18 |
Costs of vaccine programs across 94 low- and middle-income countries
|
Portnoy, Allison
|
|
2015
|
33 |
S1 |
p. A99-A108
nvt p.
|
artikel
|
| 19 |
Determinants of routine immunization costing in Benin and Ghana in 2011
|
Ahanhanzo, Césaire Damien
|
|
2015
|
33 |
S1 |
p. A66-A71
nvt p.
|
artikel
|
| 20 |
Economic analysis of the single-dose immunization strategy against hepatitis A in Argentina
|
Vizzotti, C.
|
|
2015
|
33 |
S1 |
p. A227-A232
nvt p.
|
artikel
|
| 21 |
Editorial Board/Aims and Scope
|
|
|
2015
|
33 |
S1 |
p. CO2-
1 p.
|
artikel
|
| 22 |
Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: A country-led analysis
|
Diop, Abdou
|
|
2015
|
33 |
S1 |
p. A119-A125
nvt p.
|
artikel
|
| 23 |
Estimating costs of care for meningitis infections in low- and middle-income countries
|
Portnoy, Allison
|
|
2015
|
33 |
S1 |
p. A240-A247
nvt p.
|
artikel
|
| 24 |
Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience
|
Jauregui, Barbara
|
|
2015
|
33 |
S1 |
p. A28-A33
nvt p.
|
artikel
|
| 25 |
Examining the cost of delivering routine immunization in Honduras
|
Janusz, Cara Bess
|
|
2015
|
33 |
S1 |
p. A53-A59
nvt p.
|
artikel
|
| 26 |
Foreword
|
Etienne, Carissa F.
|
|
2015
|
33 |
S1 |
p. A1-
1 p.
|
artikel
|
| 27 |
Gavi's balancing act: Accelerating access to vaccines while ensuring robust national decision-making for sustainable programmes
|
Sosler, Stephen
|
|
2015
|
33 |
S1 |
p. A4-A5
nvt p.
|
artikel
|
| 28 |
Mapping financial flows for immunisation in Uganda 2009/10 and 2010/11: New insights for methodologies and policy
|
Guthrie, Teresa
|
|
2015
|
33 |
S1 |
p. A79-A84
nvt p.
|
artikel
|
| 29 |
Perspectives on expanding the evidence base to inform vaccine introduction: Program costing and cost-effectiveness analyses
|
Andrus, Jon Kim
|
|
2015
|
33 |
S1 |
p. A2-A3
nvt p.
|
artikel
|
| 30 |
Perspectives on the development and use of economic evidence for immunization decision-making in a developing country
|
Molina-Aguilera, Ida Berenice
|
|
2015
|
33 |
S1 |
p. A6-A7
nvt p.
|
artikel
|
| 31 |
ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions
|
Jauregui, Barbara
|
|
2015
|
33 |
S1 |
p. A21-A27
nvt p.
|
artikel
|
| 32 |
Rotavirus vaccine effectiveness in Latin American and Caribbean countries: A systematic review and meta-analysis
|
Oliveira, Lúcia Helena de
|
|
2015
|
33 |
S1 |
p. A248-A254
nvt p.
|
artikel
|
| 33 |
Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe
|
Blau, Julia
|
|
2015
|
33 |
S1 |
p. A34-A39
nvt p.
|
artikel
|
| 34 |
The drivers of facility-based immunization performance and costs. An application to Moldova
|
Maceira, Daniel
|
|
2015
|
33 |
S1 |
p. A72-A78
nvt p.
|
artikel
|
| 35 |
The ProVac initiative and evolving decision support
|
Sanderson, Colin F.B.
|
|
2015
|
33 |
S1 |
p. A8-A10
nvt p.
|
artikel
|
| 36 |
Thirty years of vaccination in Vietnam: Impact and cost-effectiveness of the national Expanded Programme on Immunization
|
Jit, Mark
|
|
2015
|
33 |
S1 |
p. A233-A239
nvt p.
|
artikel
|
| 37 |
Tracking financial flows for immunization in Honduras
|
Valdés, Werner
|
|
2015
|
33 |
S1 |
p. A85-A92
nvt p.
|
artikel
|
| 38 |
What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
|
Brenzel, Logan
|
|
2015
|
33 |
S1 |
p. A93-A98
nvt p.
|
artikel
|
Tijdschrift beschrijving